These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17938769

  • 21. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A, Kavakli K, Baytan B, Kazanci E, Sayli T, Oren H, Celkan T, Gursel T.
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [Abstract] [Full Text] [Related]

  • 22. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P, Plamenová I, Hollý P, Stasko J.
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [Abstract] [Full Text] [Related]

  • 23. An unusual cause of atrial tachycardia in a young patient with lymphoma.
    Luesink M, Smeets JL, Brons PP, Kapusta L.
    Clin Pediatr (Phila); 2009 May; 48(4):449-50. PubMed ID: 18772357
    [Abstract] [Full Text] [Related]

  • 24. The use of the Port-A-Cath in children with haemophilia--a review.
    Van Den Berg HM, Fischer K, Roosendaal G, Mauser-Bunschoten EP.
    Haemophilia; 1998 Jul; 4(4):418-20. PubMed ID: 9873764
    [Abstract] [Full Text] [Related]

  • 25. A prospective clinical trial of implantable central venous access in children with haemophilia.
    Santagostino E, Gringeri A, Muça-Perja M, Mannucci PM.
    Br J Haematol; 1998 Sep; 102(5):1224-8. PubMed ID: 9753049
    [Abstract] [Full Text] [Related]

  • 26. Complications of central venous catheters in patients with haemophilia and inhibitors.
    Morado M, Jimenez-Yuste V, Villar A, Quintana M, Del Castillo F, Garzon G, Acitores I, Ibañez F, Sanjurjo MJ, Gago J, Hernandez-Navarro F.
    Haemophilia; 2001 Nov; 7(6):551-6. PubMed ID: 11851752
    [Abstract] [Full Text] [Related]

  • 27. Practice patterns in haemophilia A therapy -- global progress towards optimal care.
    Geraghty S, Dunkley T, Harrington C, Lindvall K, Maahs J, Sek J.
    Haemophilia; 2006 Jan; 12(1):75-81. PubMed ID: 16409179
    [Abstract] [Full Text] [Related]

  • 28. Septic arthritis in hemophilia with central venous catheter: a case report.
    Li CH, Ou Y, Lee AC, So KT.
    Pediatr Hematol Oncol; 2000 Mar; 17(2):187-9. PubMed ID: 10734663
    [Abstract] [Full Text] [Related]

  • 29. Transhepatic central venous catheter for long-term access in paediatric patients.
    Mortell A, Said H, Doodnath R, Walsh K, Corbally M.
    J Pediatr Surg; 2008 Feb; 43(2):344-7. PubMed ID: 18280287
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Intraoperative use of plasma-derived activated factor VII (F VII a) in a hemophilia A patient with inhibitors].
    Matsuyama K, Ushijima K, Kano T, Tsuchiya H.
    Masui; 1996 Feb; 45(2):235-8. PubMed ID: 8865715
    [Abstract] [Full Text] [Related]

  • 32. Domiciliary desensitization therapy for young boys with haemophilia and factor VIII inhibitors.
    Lilleyman JS.
    Br J Haematol; 1994 Feb; 86(2):433-5. PubMed ID: 8199043
    [Abstract] [Full Text] [Related]

  • 33. The German Registry of immune tolerance treatment in hemophilia--1999 update.
    Lenk H, ITT Study Group.
    Haematologica; 2000 Oct; 85(10 Suppl):45-7. PubMed ID: 11187870
    [Abstract] [Full Text] [Related]

  • 34. Inadvertent anticoagulation of a haemophiliac child with routine line flushing.
    Lambert C, Deneys V, Pothen D, Vermylen C, Hermans C.
    Haemophilia; 2006 Sep; 12(5):548-50. PubMed ID: 16919088
    [Abstract] [Full Text] [Related]

  • 35. Low risk of inhibitor formation in haemophilia patients after a change in treatment from Chinese hamster ovary cell-produced to baby hamster kidney cell-produced recombinant factor VIII.
    Singleton E, Smith J, Kavanagh M, Nolan B, White B.
    Thromb Haemost; 2007 Dec; 98(6):1188-92. PubMed ID: 18064312
    [Abstract] [Full Text] [Related]

  • 36. Bacterial endocarditis and septic arthritis in a patient with severe hemophilia A: a case report.
    Titapiwatanakun R, Pruthi RK, Schmidt K, Slaby JA, Rodriguez V.
    J Pediatr Hematol Oncol; 2009 May; 31(5):344-5. PubMed ID: 19415014
    [Abstract] [Full Text] [Related]

  • 37. [Cardiac resynchronization therapy in non-ischemic cardiomyopathy].
    Weretka S, Rüb N, Weig HJ, Laszlo R, Dörnberger V, Gawaz M, Schreieck J.
    Dtsch Med Wochenschr; 2008 May; 133 Suppl():F2. PubMed ID: 18850520
    [Abstract] [Full Text] [Related]

  • 38. rVIIa therapy to secure haemostasis during central line insertion in children with high-responding FVIII inhibitors.
    Smith OP, Hann IM.
    Br J Haematol; 1996 Mar; 92(4):1002-4. PubMed ID: 8616058
    [Abstract] [Full Text] [Related]

  • 39. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland.
    Vepsäläinen K, Lassila R, Arola M, Lähteenmäki P, Möttönen M, Mäkipernaa A, Riikonen P.
    Haemophilia; 2015 Nov; 21(6):747-53. PubMed ID: 25832453
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.